NDC 0054-0379

Sodium Polystyrene Sulfonate

Sodium Polystyrene Sulfonate

Sodium Polystyrene Sulfonate is a Oral; Rectal Suspension in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp.. The primary component is Sodium Polystyrene Sulfonate.

• Product ID: 0054-0379_4176ae6b-23c9-4786-a7ac-1fb6405a5254
• NDC: 0054-0379
• Product Type: Human Prescription Drug
• Proprietary Name: Sodium Polystyrene Sulfonate
• Generic Name: Sodium Polystyrene Sulfonate
• Dosage Form: Suspension
• Route of Administration: ORAL; RECTAL
• Marketing Start Date: 2013-06-17
• Marketing Category: ANDA / ANDA
• Application Number: ANDA089049
• Labeler Name: West-Ward Pharmaceuticals Corp.
• Substance Name: SODIUM POLYSTYRENE SULFONATE
• Active Ingredient Strength: 15 g/60mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0054-0379-51

60 mL in 1 BOTTLE, UNIT-DOSE (0054-0379-51)

• Marketing Start Date: 2013-06-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0054-0379-63 [00054037963]

Sodium Polystyrene Sulfonate SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA089049
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2013-06-17
• Marketing End Date: 2021-01-31

NDC 0054-0379-50 [00054037950]

Sodium Polystyrene Sulfonate SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA089049
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2013-06-17
• Marketing End Date: 2021-01-31

NDC 0054-0379-55 [00054037955]

Sodium Polystyrene Sulfonate SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA089049
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2013-06-17
• Marketing End Date: 2021-01-31

NDC 0054-0379-51 [00054037951]

Sodium Polystyrene Sulfonate SUSPENSION

• Marketing Category: ANDA
• Application Number: ANDA089049
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2013-06-17
• Marketing End Date: 2021-01-31

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM POLYSTYRENE SULFONATE	15 g/60mL

OpenFDA Data

• SPL SET ID: 83f3f990-4fab-43c7-9100-092d64ab6213
• Manufacturer:
  • West-Ward Pharmaceuticals Corp.
• UNII:
  • 1699G8679Z
• RxNorm Concept Unique ID - RxCUI:
  • 313072

NDC Crossover Matching brand name "Sodium Polystyrene Sulfonate" or generic name "Sodium Polystyrene Sulfonate"

NDC	Brand Name	Generic Name
0054-0379	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
0574-2003	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
10135-146	Sodium Polystyrene Sulfonate	sodium polystyrene sulfonate
10702-036	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
11534-166	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate
13811-656	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
17856-0036	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
17856-0831	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
17856-1136	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
24658-760	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
42806-013	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
46287-006	Sodium Polystyrene Sulfonate	sodium polystyrene sulfonate
46287-012	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
50488-5001	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
51293-831	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
55154-7353	Sodium Polystyrene Sulfonate	sodium polystyrene sulfonate
62135-340	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
62250-660	SODIUM POLYSTYRENE SULFONATE	SODIUM POLYSTYRENE SULFONATE
63629-2031	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
70166-712	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate
0574-2002	Kionex	Sodium Polystyrene Sulfonate